Related Experiment Video
Updated: Feb 19, 2026
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.3K
Pivotal Trials in Heart Failure in 2024-Putting Evidence into Clinical Practice!
Prashant Thandi1, Akshyaya Pradhan1, Suresh Kumar Behera2
1Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
Summary
Recent heart failure research highlights advancements in therapies for preserved and reduced ejection fraction, offering new strategies to combat the growing epidemic and improve patient care.
Area of Science:
- Cardiology
- Heart Failure Research
- Clinical Medicine
Background:
- Heart failure (HF) management is complex due to physiological, psychological, and social factors.
- Understanding HF epidemiology, pathophysiology, predictors, and diagnostics is crucial for developing new therapies.
- A growing HF epidemic necessitates innovative therapeutic strategies.
Purpose of the Study:
- To provide an overview of key studies presented at recent scientific meetings.
- To highlight recent advancements in heart failure therapies.
- To inform innovative strategies for decelerating the heart failure epidemic.
Main Methods:
- Review of key studies presented at scientific meetings over the past year.
- Analysis of recent developments in cardiovascular medicine related to heart failure.
- Synthesis of evidence for improved patient care and clinical outcomes.
Main Results:
- Significant advancements in therapies for both heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).
- Valuable insights from recent studies in cardiovascular medicine.
- Evidence supporting a more integrated approach to patient care.
Conclusions:
- Recent studies offer potential to revolutionize heart failure treatment strategies.
- Advancements advocate for enhanced patient care and improved clinical outcomes.
- The presented research promises to improve overall heart failure management.
Keywords:
diabetic cardiomyopathyempaglifozinfinerenoneheart failurenon-obstructive HCMobesitysemaglutideMore Related Videos
Related Concept Videos
01:16Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:26Heart Failure III: Clinical Manifestations
658
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
658
01:30Heart Failure V: Medical Management
377
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
377
01:22Heart Failure VI: Adjunct Therapies
417
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
417
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K